Organogenesis Holdings (ORGO) Other Working Capital Changes (2018 - 2026)
Organogenesis Holdings' (ORGO) quarterly Other Working Capital Changes came in at $1.7 million in Q1 2026, down 67.69% year-on-year from $5.1 million in Q1 2025, and up 153.13% quarter-over-quarter from -$3.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Organogenesis Holdings' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 67.69% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was -$3.3 million, a 197.86% decrease from a year earlier, with the FY2025 full-year figure at $183000.0, down 92.82% from the prior year.
- Other Working Capital Changes improved to $1.7 million in Q1 2026 per ORGO's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.8 million in Q2 2025 and bottomed at -$9.6 million in Q3 2025.
- The 5-year median for Other Working Capital Changes is $1.6 million (2023), against an average of $875294.1.
- Biggest YoY gain for Other Working Capital Changes was 1383.91% in 2023; the steepest drop was 482.82% in 2023.
- Year by year, Other Working Capital Changes stood at $379000.0 in 2022, then jumped by 1383.91% to $5.6 million in 2023, then plunged by 126.72% to -$1.5 million in 2024, then sank by 107.25% to -$3.1 million in 2025, then surged by 153.13% to $1.7 million in 2026.
- Per Business Quant, the three latest ORGO Other Working Capital Changes figures stand at $1.7 million (Q1 2026), -$3.1 million (Q4 2025), and -$9.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Sep 30, 2025 | -9.64 Mn |
| Sep 30, 2025 | -9.64 Mn |
| Sep 30, 2025 | -9.64 Mn |
| Jun 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 7.82 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 3.62 Mn |
| Sep 30, 2024 | 3.62 Mn |